1. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two. Issue 1 (November 2016) Authors: Ager, Casey; Reilley, Matthew; Nicholas, Courtney; Bartkowiak, Todd; Jaiswal, Ashvin; Curran, Michael; Albershardt, Tina; Bajaj, Anshika; Archer, Jacob; Reeves, Rebecca; Ngo, Lisa; Berglund, Peter; ter Meulen, Jan; Denis, Caroline; Ghadially, Hormas; Arnoux, Thomas; Chanuc, Fabien; Fuseri, Nicola... Journal: Journal for immunotherapy of cancer Issue: Volume 4:Issue 1(2016) Page Start: 107 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two. Issue 1 (November 2016) Authors: Ager, Casey; Reilley, Matthew; Nicholas, Courtney; Bartkowiak, Todd; Jaiswal, Ashvin; Curran, Michael; Albershardt, Tina; Bajaj, Anshika; Archer, Jacob; Reeves, Rebecca; Ngo, Lisa; Berglund, Peter; ter Meulen, Jan; Denis, Caroline; Ghadially, Hormas; Arnoux, Thomas; Chanuc, Fabien; Fuseri, Nicola... Journal: Journal for immunotherapy of cancer Issue: Volume 4:Issue 1(2016) Page Start: 107 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two: National Harbor, MD, USA. 9-13 November 2016. (16th November 2016) Authors: Ager, Casey; Reilley, Matthew; Nicholas, Courtney; Bartkowiak, Todd; Jaiswal, Ashvin; Curran, Michael; Albershardt, Tina C.; Bajaj, Anshika; Archer, Jacob F.; Reeves, Rebecca S.; Ngo, Lisa Y.; Berglund, Peter; ter Meulen, Jan; Denis, Caroline; Ghadially, Hormas; Arnoux, Thomas; Chanuc, Fabien; Fu... Journal: Journal for immunotherapy of cancer Issue: Volume 4(2016)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 385 A first-in-human study of lemzoparlimab, a differentiated anti-CD47 antibody, in subjects with relapsed/refractory malignancy: initial monotherapy results. (10th December 2020) Authors: Berlin, Jordan; Harb, Wael; Adjei, Alex; Xing, Yan; Swiecicki, Paul; Seetharam, Mahesh; Nandagopal, Lakshminarayanan; Gopal, Ajay; Xu, Cong; Xu, Cong; Meng, Yuan; Lee, Linda; Zhao, Yonggang; Wang, Zhengyi; Shen, Joan Huaqiong Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A233 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 385 A first-in-human study of lemzoparlimab, a differentiated anti-CD47 antibody, in subjects with relapsed/refractory malignancy: initial monotherapy results. (9th November 2020) Authors: Berlin, Jordan; Harb, Wael; Adjei, Alex; Xing, Yan; Swiecicki, Paul; Seetharam, Mahesh; Nandagopal, Lakshminarayanan; Gopal, Ajay; Xu, Cong; Xu, Cong; Meng, Yuan; Lee, Linda; Zhao, Yonggang; Wang, Zhengyi; Shen, Joan Huaqiong Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A410 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. The impact of histological grade on outcomes in follicular lymphoma: An analysis of patients in the SEER database in the context of evolving disease classification and treatment. (16th August 2022) Authors: Naik, Anisha; Gooley, Ted; Loeb, Keith; Soma, Lorinda; Smith, Stephen D.; Gopal, Ajay; Naresh, Kikkeri N. Journal: British journal of haematology Issue: Volume 199:Number 5(2022) Page Start: 696 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗